Globeimmune Inc
Advertisement
GlobeImmune Inc., based in Louisville, Colorado, is dedicated to developing innovative Tarmogen product candidates aimed at treating cancer and infectious diseases. Their Tarmogen technology activates the immune system by stimulating T cells, which are critical in targeting and destroying infected or malignant cells, distinguishing them from traditional vaccines that primarily focus on antibody production.
The company's approach leverages the unique molecular profiles that differentiate diseased cells from healthy ones, aiming to target specific antigens relevant to oncology and infectious disease treatments. Through their advanced pipeline, GlobeImmune is poised to make significant contributions to the field of molecular immunotherapy.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
Advertisement